TYK Medicines, Inc (HKG:2410)
Hong Kong · Delayed Price · Currency is HKD 11.10
+0.33 (3.06%)
At close: Mar 6, 2026
TYK Medicines Market Cap
TYK Medicines has a market cap or net worth of 4.22 billion as of March 6, 2026. Its market cap has decreased by -51.69% in one year.
Market Cap
4.22B
Enterprise Value
3.98B
Revenue
117.25K
Ranking
n/a
PE Ratio
n/a
Stock Price
11.10
Market Cap Chart
Since August 20, 2024, TYK Medicines's market cap has decreased from 5.08B to 4.22B, a decrease of -16.96%. That is a compound annual growth rate of -11.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 4.22B | -15.33% |
| Dec 31, 2025 | 4.98B | -71.50% |
| Dec 31, 2024 | 17.48B | 244.16% |
| Aug 20, 2024 | 5.08B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ocumension Therapeutics | 5.26B |
| Beijing Luzhu Biotechnology | 4.87B |
| Laekna | 4.70B |
| Mirxes Holding Company | 4.50B |
| Viva Biotech Holdings | 4.41B |
| Shandong Boan Biotechnology | 4.39B |
| Jacobio Pharmaceuticals Group | 4.31B |
| AIM Vaccine | 3.66B |